Efficacy of Spa Management (Hydrokinesitherapy and Crenobalneotherapy) Compared With Usual Management of People With Post-Covid-19 Conditions: a Randomized, Open-label Clinical Trial.

Publication date: Aug 22, 2024

Following the acute phase of Covid-19, some patients experience persistent or recurrent symptoms. These symptoms can take a number of forms: intense fatigue, cognitive dysfunction, respiratory difficulties, maladaptation to physical exertion, musculoskeletal pain, anxiety-depressive disorders, malnutrition, loss of sense of smell, headaches and so on. These symptoms are known as post-covid-19 disease, defined by the WHO as “a condition occurring in people with a history of probable or confirmed infection with SARS-CoV-2, usually 3 months after the onset of COVID-19 with symptoms that persist for at least 2 months and cannot be explained by another diagnosis. Common symptoms include fatigue, breathlessness and cognitive dysfunction, as well as other symptoms that generally have an impact on daily functioning. The aim of this interventional research project is to assess the place of a specific spa treatment for people with a post-Covid 19 condition in the primary care pathway.

Concepts Keywords
Aerobath Acute
June Care
Norwegian Covid
Thromboembolism Eq
Zurich Inclusion
Months
Patient
Period
Post
Primary
Protocol
Spa
Symptoms
Treatment
Weeks

Semantics

Type Source Name
disease MESH Covid-19
disease MESH cognitive dysfunction
disease MESH musculoskeletal pain
disease MESH depressive disorders
disease MESH malnutrition
disease IDO history
disease MESH infection
disease VO vaccinated
disease MESH post-Covid condition
disease MESH cardiovascular disease
disease MESH acute coronary syndrome
disease MESH arrhythmia
disease MESH heart failure
disease MESH venous thromboembolism
disease MESH myocarditis
disease MESH stroke acute
disease MESH COPD
disease MESH fibrosis
disease VO pregnant women
disease MESH panic attacks
disease MESH syndrome
disease MESH contraindication
disease MESH dermatoses
disease MESH urinary incontinence
disease MESH hydrophobia

Original Article

(Visited 1 times, 1 visits today)